Modimelanotide
id:
modimelanotide-193-13966231
title:
Modimelanotide
text:
Modimelanotide (INN) is a melanocortinergic peptide drug derived from α-melanocyte-stimulating hormone (α-MSH) which was under development by, at different times, Action Pharma, Abbott Laboratories, AbbVie, and Zealand for the treatment of acute kidney injury. It acts as a non-selective melanocortin receptor agonist, with IC50 values of 2.9 nM, 1.9 nM, 3.7 nM, and 110 nM at the MC1, MC3, MC4, and MC5 receptors. Modimelanotide failed clinical trials for acute kidney injury despite showing efficac
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Modimelanotide
date created:
date modified:
2023-05-13T12:45:44Z
main entity:
{"identifier":"Q20707053","url":"https://www.wikidata.org/entity/Q20707053"}
image:
fields total:
13
integrity:
14